Neogen says Australia, New Zealand review of genomics sale to Zoetis to conclude early 2027

Neogen says the Australian and New Zealand review of its genomics sale to Zoetis is expected to conclude early 2027, and that Zoetis has offered to divest some Australian assets.

Detected & updated continuously · Source: Nebula